Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today reported results for the quarter and year ended December 31, 2012.
“Our efforts over the past year clearly demonstrate Teva’s ability and commitment to transform the Company. Based on this, we will enter 2013 with a strong and disciplined business focus,” stated Dr. Jeremy Levin, Teva’s President and Chief Executive Officer.
